Akero Therapeutics (AKRO) Insider Trading & Ownership $47.57 +9.43 (+24.72%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Akero Therapeutics (NASDAQ:AKRO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.94%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$15.86 MNumber OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$37.45 M Get AKRO Insider Trade Alerts Want to know when executives and insiders are buying or selling Akero Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AKRO Insider Buying and Selling by Quarter Akero Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/15/2025Catriona YaleInsiderSell10,000$39.30$393,000.00 5/12/2025Andrew ChengCEOSell30,000$41.48$1,244,400.00 5/7/2025Patrick LamyVPSell8,000$42.49$339,920.00 5/6/2025Timothy RolphInsiderSell12,500$43.43$542,875.00 4/24/2025Timothy RolphInsiderSell6,250$41.03$256,437.50 4/15/2025Catriona YaleInsiderSell9,073$37.91$343,957.43 4/10/2025Andrew ChengCEOSell30,000$35.23$1,056,900.00 4/7/2025Timothy RolphInsiderSell6,250$35.88$224,250.00 3/27/2025G. Walmsley GrahamDirectorBuy50,000$43.55$2,177,500.00 3/25/2025G. Walmsley GrahamDirectorBuy91,309$44.75$4,086,077.75 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/17/2025Catriona YaleInsiderSell10,000$44.76$447,600.00 3/12/2025Andrew ChengCEOSell1,738$44.88$78,001.44 3/12/2025Catriona YaleInsiderSell614$44.88$27,556.32 3/12/2025Jonathan YoungCOOSell607$44.88$27,242.16 3/12/2025William Richard WhiteCFOSell676$44.88$30,338.88 3/10/2025Andrew ChengCEOSell30,000$41.77$1,253,100.00 3/5/2025Timothy RolphInsiderSell12,500$44.53$556,625.00 3/4/2025Jonathan YoungCOOSell50,000$44.86$2,243,000.00 3/3/2025Patrick LamyVPSell1,000$48.09$48,090.00 2/18/2025Catriona YaleInsiderSell10,000$49.87$498,700.00 2/10/2025Andrew ChengCEOSell30,000$52.73$1,581,900.00 2/5/2025Timothy RolphInsiderSell18,750$56.51$1,059,562.50 2/3/2025Jonathan YoungCOOSell10,000$53.81$538,100.00 1/30/2025G. Walmsley GrahamDirectorBuy200,000$48.00$9,600,000.00 1/27/2025Andrew ChengCEOSell30,000$54.90$1,647,000.00 1/27/2025Patrick LamyVPSell5,000$57.03$285,150.00 1/27/2025Timothy RolphInsiderSell31,250$55.77$1,742,812.50 1/2/2025Jonathan YoungCOOSell10,000$28.03$280,300.00 12/16/2024Catriona YaleInsiderSell9,074$29.11$264,144.14 12/16/2024Patrick LamyVPSell1,000$29.13$29,130.00 12/10/2024Andrew ChengCEOSell7,855$30.79$241,855.45 12/10/2024Jonathan YoungCOOSell2,503$30.79$77,067.37 12/10/2024Patrick LamyVPSell925$30.79$28,480.75 12/10/2024Timothy RolphInsiderSell4,818$30.91$148,924.38 12/10/2024William Richard WhiteCFOSell2,817$30.79$86,735.43 12/2/2024Andrew ChengCEOSell25,000$32.09$802,250.00 12/2/2024Jonathan YoungCOOSell10,000$32.13$321,300.00 11/15/2024Catriona YaleInsiderSell9,061$27.73$251,261.53 11/1/2024Andrew ChengCEOSell108,366$31.73$3,438,453.18 11/1/2024Catriona YaleInsiderSell15,485$32.62$505,120.70 Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos11/1/2024Jonathan YoungCOOSell50,716$31.57$1,601,104.12 10/30/2024Catriona YaleInsiderSell4,515$32.53$146,872.95 10/18/2024Andrew ChengCEOSell63,539$31.53$2,003,384.67 10/16/2024Andrew ChengCEOSell24,992$31.14$778,250.88 10/14/2024Catriona YaleInsiderSell6,136$30.03$184,264.08 10/14/2024Jonathan YoungCOOSell40,000$30.15$1,206,000.00 10/1/2024Jonathan YoungCOOSell10,000$28.18$281,800.00 9/20/2024Catriona YaleInsiderSell5,500$27.65$152,075.00 9/18/2024Catriona YaleInsiderSell3,871$27.56$106,684.76 9/16/2024Catriona YaleInsiderSell2,485$27.52$68,387.20 9/10/2024Andrew ChengCEOSell1,738$26.18$45,500.84 9/10/2024Catriona YaleInsiderSell637$26.18$16,676.66 9/10/2024Jonathan YoungCOOSell568$26.18$14,870.24 9/10/2024William Richard WhiteCFOSell639$26.18$16,729.02 8/26/2024Catriona YaleInsiderSell5,200$27.51$143,052.00 8/26/2024William Richard WhiteCFOSell75,159$27.21$2,045,076.39 8/23/2024Catriona YaleInsiderSell8,851$27.53$243,668.03 8/1/2024Jonathan YoungCOOSell5,000$26.75$133,750.00 7/24/2024William Richard WhiteCFOSell139,083$26.98$3,752,459.34 7/16/2024William Richard WhiteCFOSell34,811$28.04$976,100.44 7/1/2024Jonathan YoungCOOSell5,000$23.40$117,000.00 6/11/2024Andrew ChengCEOSell7,894$22.64$178,720.16 6/11/2024Catriona YaleInsiderSell2,825$22.64$63,958.00 6/11/2024Jonathan YoungCOOSell2,516$22.64$56,962.24 6/11/2024Patrick LamyVPSell569$22.64$12,882.16 6/11/2024William Richard WhiteCFOSell2,831$22.64$64,093.84 6/3/2024Jonathan YoungCOOSell5,000$19.29$96,450.00 (Data available from 1/1/2013 forward) AKRO Insider Trading Activity - Frequently Asked Questions Who is on Akero Therapeutics's Insider Roster? The list of insiders at Akero Therapeutics includes Andrew Cheng, Catriona Yale, G. Walmsley Graham, Jonathan Young, Patrick Lamy, Seth Loring Harrison, Skorpios Trust, Timothy Rolph, Tomas J. Heyman, and William Richard White. Learn more on insiders at AKRO. What percentage of Akero Therapeutics stock is owned by insiders? 7.94% of Akero Therapeutics stock is owned by insiders. Learn more on AKRO's insider holdings. Which Akero Therapeutics insiders have been buying company stock? The following insider purchased AKRO shares in the last 24 months: G. Walmsley Graham ($22,105,277.75). How much insider buying is happening at Akero Therapeutics? Insiders have purchased a total of 571,309 AKRO shares in the last 24 months for a total of $22,105,277.75 bought. Which Akero Therapeutics insiders have been selling company stock? The following insiders have sold AKRO shares in the last 24 months: Andrew Cheng ($22,119,745.69), Catriona Yale ($6,312,160.13), Jonathan Young ($7,882,210.97), Patrick Lamy ($743,652.91), Timothy Rolph ($8,843,359.32), Tomas J. Heyman ($1,421,420.00), and William Richard White ($8,192,194.54). How much insider selling is happening at Akero Therapeutics? Insiders have sold a total of 1,501,224 Akero Therapeutics shares in the last 24 months for a total of $55,514,743.56 sold. Akero Therapeutics Key ExecutivesDr. Andrew Cheng M.D. (Age 57)Ph.D., President, CEO & Director Compensation: $1.04MDr. Jonathan M. Young J.D. (Age 54)Ph.D., Co-Founder, Executive VP, COO & Secretary Compensation: $672.35kDr. Timothy Rolph (Age 70)Co-Founder & Chief Scientific Officer Compensation: $722.32k7 recent tradesMr. William R. White J.D. (Age 51)Executive VP, CFO, Treasurer & Head of Corporate Development Compensation: $678.06kMs. Catriona Yale (Age 52)Executive VP & Chief Development Officer Compensation: $678.06k6 recent tradesMr. Scott A. Gangloff (Age 50)Chief Technical Officer Mr. David West J.D.Vice President of LegalMr. John J. Schembri (Age 62)Vice President & Head of Finance Mr. Patrick Lamy (Age 51)Senior Vice President of Commercial Strategy 5 recent trades More Insider Trading Tools from MarketBeat Related Companies Genmab A/S Insider Selling Viatris Insider Selling Moderna Insider Selling Roivant Sciences Insider Selling Revolution Medicines Insider Selling BridgeBio Pharma Insider Selling Blueprint Medicines Insider Selling Elanco Animal Health Insider Selling TG Therapeutics Insider Selling Verona Pharma Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market CapMcDonald’s Insiders Sell Shares! Investors Should Do the Opposite This page (NASDAQ:AKRO) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akero Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akero Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AKRO Stock Free AKRO Stock Alerts